Fundraising Fox

TriSalus Life Sciences

NASDAQ: TLSI

Westminster, US · Founded 2020 · Delaware corporation

BiotechHealthtech

Founders & leadership

SM
Sean MurphyExecutive
JE
Jennifer E. StevensExecutive
RB
Richard B. MarshakExecutive
MS
Mary SzelaExecutive
JD
Jodi DevlinExecutive
RH
Robert H. WeissChief Administrative Officer and Secretary
CC
Christopher C. DeweyChief Executive Officer
DL
David L. TreadwellNamed on SEC filing
MR
Martin RocheNamed on SEC filing
MA
Manuel AgueroNamed on SEC filing
TT
Thierry ThaureNamed on SEC filing

Board

DM
David MatlinBoard director

Reported raises · per SEC filings

Form D private placements

$40.9M disclosed across 3 rounds · 2023–2025

▶$22MraisedMay 2025 · 24 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mats WahlstromDirector
  • Jennifer StevensExecutive Officer
  • David J. MatlinDirector
  • Jodi DevlinExecutive Officer
  • Arjun DesaiDirector
  • Sean MurphyDirector
  • Richard MarshakExecutive Officer
  • Gary GordonDirector
  • James YoungExecutive Officer
  • Mary SzelaExecutive Officer, Director
  • Andrew von EschenbachDirector
  • Kerry HicksDirector
  • Brian CoxExecutive Officer
  • William F. ValleDirector
Offering amount
$22M
Amount sold
$22M
First sale
May 2025
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1000KraisedDec 2024 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sean MurphyExecutive Officer, Director
  • Kerry HicksDirector
  • Jennifer E. StevensExecutive Officer
  • Mats WahlstromDirector
  • Richard B. MarshakExecutive Officer
  • Liselotte HyveledDirector
  • David MatlinDirector
  • Mary SzelaExecutive Officer, Director
  • Jodi DevlinExecutive Officer
  • Arjun DesaiDirector
  • George Kelly MartinDirector
  • Andrew von EschenbachDirector
  • Bryan F. CoxExecutive Officer
Offering amount
$1000K
Amount sold
$1000K
First sale
Dec 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.9MraisedJun 2023 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert H. WeissExecutive Officer
  • David L. TreadwellDirector
  • Karim KartiDirector
  • Martin RocheDirector
  • Christopher C. DeweyExecutive Officer, Director
  • Manuel AgueroDirector
  • Thierry ThaureDirector
  • David J. MatlinExecutive Officer, Director
Offering amount
$50M
Amount sold
$17.9M
Sales commissions
$3.3M
Placement agents
Ceros Financial Services, Inc.
First sale
Jun 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has TriSalus Life Sciences raised?
TriSalus Life Sciences has disclosed $40.9M raised across 3 rounds.
Where is TriSalus Life Sciences headquartered?
TriSalus Life Sciences is headquartered in Westminster, US.